ABcann Global Corporation (TSX-V:ABCN) (Frankfurt:23Q) (OTCQB:ABCCF) is pleased to provide an update on the Company's construction and expansion timelines for its Vanluven and Kimmett facilities, both located in Napanee, Ontario.
Articles
Lexaria Bioscience’s (CSE: LXX) (OTCQB: LXRP) Patented Cannabinoid Delivery System Approved
Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) has patented and licenses a novel delivery system which infuses organically sourced hemp oil into the molecules of other substances.
Tecogen Makes First Sale into Florida's Indoor Grow Facility Industry
Tecogen® Inc. (NASDAQ: TGEN), a clean energy company providing ultra-efficient, clean, natural gas-powered on-site power, heating and cooling equipment, is pleased to announce the sale of three of its Tecochill "STx Series" chillers to an indoor cannabis growing operation near Tampa, FL. This marks Tecogen's first sale into Florida's recently legalized medical marijuana business.
OWC Pharmaceutical Research Corp Appoints Dr. Stanley Hirsch as its Active Chairman
OWC Pharmaceutical Research Corp. (OTCQB: OWCP), ("OWC" or the "Company"), a developer of cannabinoid-based therapies targeting a variety of different medical conditions and disorders, today announced the appointment of Dr. Stanley Hirsch as its active chairman of the board of directors.
Pot charges drop in 2016, Statistics Canada reports
The number of cannabis-related offences reported to police and the number of pot possession charges were down again last year.
Tetra Bio-Pharma Accelerates Growth Strategy with Appointment of Bernard Fortier as CEO
Tetra Bio-Pharma Inc. (“Tetra” or the “Company“) (CSE:TBP)(CSE:TBP.CN)(CNSX:TBP)(OTCQB:TBPMF) today announced that it has strengthened its management team with the appointment of Bernard Fortier to the position of Chief Executive Officer, effective today, July 24, 2017.
ChineseInvestors.com, Inc. (CIIX) Subsidiary Files Record of ‘CBD Magic Hemp Series’ Product Line Ahead of Impending Launch
Market analysis company ChineseInvestors.com, Inc. (OTCQB: CIIX) this morning announced that its wholly-owned foreign enterprise, CBD Biotechnology Co. Ltd., has officially filed a record of its first line of non-industrial hemp-infused skin care products with the China Food and Drug Administration (CFDA).
InMed Pharmaceuticals, Inc. (OTCMKTS:IMLFF) Closes R&D Contract With ATERA
InMed Pharmaceuticals, Inc. (OTCMKTS:IMLFF) has closed a research and development contract with ATERA SAS of France, a key tissue engineering entity specializing in the advancement of innovative human tissue models.
Aurora Cannabis : Starts Trading on Toronto Stock Exchange
Aurora Cannabis Inc. (the "Company" or "Aurora") (TSXV: ACB) (OTCQX: ACBFF) ( Frankfurt : 21P; WKN: A1C4WM) announced today that common shares of the Company will commence trading on Toronto Stock Exchange (the "TSX") effective Monday July 24 . Common shares will continue to trade under the symbol "ACB".
The strategic approach of ABcann’s growth technique
Aaron Keay, CEO of ABcann Global Corporation, speaks with Natasha Frakes about why the company waited two years from getting their license before going public.
Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) Commences Lab Work with National Research Council of Canada
Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) this morning announced the start of laboratory work under its collaborative research project with the National Research Council of Canada (“NRC”).
Lotus Announces Construction Start, Private Placement and Terms of Cannabis Wheaton Streaming Deal
Lotus Ventures Inc. (“Lotus” or the “Company”) (CSE:J) is pleased to announce a non-brokered private placement offering (the “Offering”), the start of facility construction, provide details on its streaming agreement with Cannabis Wheaton Income Corp. (“CBW”) and an update on the regulatory licensing process.
InMed Pharmaceuticals, Inc. (OTCMKTS:IMLFF) Focus On Advancing Key Trials
ATERA specializes in the advancement, validation, commercialization and manufacturing of advanced tissue models as cost-effective, high-quality, reliable and more conscientious alternatives for animal trials. Under the deal, ATERA will advance 3D human skin models of Epidermolysis Bullosa to assess the efficiency of INM-750 and probe the beneficial effects of topically put INM-750 at ultra-structural molecular and cellular levels.
Puration Acquires 25 Greenhouse Grow Operation Entering $20 Billion Marijuana Market Opportunity
Puration, Inc. (USOTC: PURA) today announced the acquisition of a 25-greenhouse grow operation. PURA operates a U.S. Patented Cannabis Extraction process and sells its extracts for infusion into a variety of consumer products.
The strategic approach of ABcann’s growth technique
Aaron Keay, CEO of ABcann Global Corporation, speaks with Natasha Frakes about why the company waited two years from getting their license before going public.